LENZ Therapeutics Financial Overview
LENZ Therapeutics's market cap is currently $563.22M. The company's EPS TTM is $-0.59; its P/E ratio is -8.36; LENZ Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
